Skip to main content
Log in

Rationale for the selection and use of in vitro assays to screen for chemopreventive agents

  • Published:
Methods in Cell Science

Abstract

This issue reports the methods of twelve in vitro assays currently being used to screen potential chemopreventive agents for activity. These assays provide quantitative data to help determine the efficacy and prioritize agents for further development in whole animal screening. It is essential that such in vitro assays provide accurate, consistent, and relevant data to identify and prioritize agents with the most promise to prevent human cancer. The twelve assays presented in this volume are currently providing such data to the National Cancer Institute's Chemoprevention Program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kelloff GJ, Boone CW, Malone WF, Steele VE (1992). Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ (eds), Cancer chemoprevention. Boca Raton: CRC Press, pp 41–56.

    Google Scholar 

  2. Kelloff GJ, Boone CW, Malone WF, Steele VE (1993). Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. Basic Life Sci 61: 373–386.

    Google Scholar 

  3. Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994). Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54: 2015S–2024S.

    Google Scholar 

  4. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC (1994). Chemopreventive drug development: Perspectives and progress. Cancer Epidemiol Biomarkers Prev 3: 85–98.

    Google Scholar 

  5. Greenwald P, Kelloff G, Burch-Whitman C, Kramer BS (1995). Chemoprevention. CA Cancer J Clin 45: 31–49.

    Google Scholar 

  6. Steele VE, Sharma S, Mehta R, Elmore E, Redpath JL, Rudd C, Baghari D, Sigman CC, Kelloff GJ (1996). Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cellular Biochem 26 (suppl): 23–46.

    Google Scholar 

  7. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich MJ, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW, Kelloff GJ (1994). Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI Chemoprevention Drug Development Program. J Cellular Biochem 20 (suppl): 32–54.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steele, V.E., Boone, C.W., Lubet, R.A. et al. Rationale for the selection and use of in vitro assays to screen for chemopreventive agents. Methods Cell Sci 19, 1–2 (1997). https://doi.org/10.1023/A:1009772307902

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009772307902

Navigation